Psychiatry and Neurology, Neurology · Chicago, IL
NPI
1932142833
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
5841 S Maryland Ave
Chicago, IL, 60637
Phone (888) 824-0200
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
363 services
Medicare patients, 2024
245
Average age 64
Drug cost, 2024
$4.4M
2,751 prescriptions
Company payments, 2025
$32K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adil Javed was code 99214 (office e&m - established), 173 times for 122 patients. In total Adil Javed billed 363 services in 11 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 173 | 122 | $77.89 | $13K |
| 99214 Office E&M - Established | Office | 105 | 69 | $92.62 | $9,725 |
| 99204 Office E&M - New | Facility | 22 | 22 | $119.67 | $2,633 |
| 99213 Office E&M - Established | Facility | 14 | 12 | $50.25 | $703 |
By year: 2022 $40K for 460 services; 2023 $38K for 442 services; 2024 $32K for 363 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adil Javed prescribed most often to Medicare patients was Gabapentin, with 303 prescriptions and refills. In total Adil Javed wrote 2,751 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 303 | 464 | 66 | $5,384 |
| Baclofen Generic | 291 | 501 | 77 | $5,947 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 169 | 169 | 24 | $3,114 |
| Tramadol Hcl Generic | 122 | 122 | 25 | $1,007 |
| Tizanidine Hcl Generic | 116 | 206 | 26 | $1,544 |
| Duloxetine Hcl Generic | 93 | 144 | 18 | $1,323 |
| Aubagio Teriflunomide | 86 | 112 | 12 | $967K |
| Modafinil Generic | 81 | 95 | 16 | $4,935 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 69 | 150 | 17 | $1,274 |
| Pregabalin Generic | 67 | 83 | 21 | $1,271 |
| Dalfampridine Er Dalfampridine | 54 | 79 | Under 11 | $19K |
| Copaxone Glatiramer Acetate | 51 | 56 | Under 11 | $275K |
| Kesimpta Pen Ofatumumab | 51 | 67 | Under 11 | $505K |
| Clonazepam Generic | 51 | 80 | 12 | $393 |
| Alprazolam Generic | 48 | 58 | Under 11 | $251 |
Brand drugs: 418 claims; generic drugs: 2,320 claims; opioid claims: 298.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adil Javed $32K ($32K in general payments such as food, travel and fees) from 11 companies. The largest payer was TG Therapeutics, Inc. with $18K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.